Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study.

Rice MB, Li W, Schwartz J, Di Q, Kloog I, Koutrakis P, Gold DR, Hallowell RW, Zhang C, O'Connor G, Washko GR, Hunninghake GM, Mittleman MA.

Thorax. 2019 Aug 7. pii: thoraxjnl-2018-212877. doi: 10.1136/thoraxjnl-2018-212877. [Epub ahead of print]

PMID:
31391318
2.

Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study.

Washko GR, Colangelo LA, Estépar RSJ, Ash SY, Bhatt SP, Okajima Y, Liu K, Jacobs, Iribarren C, Thyagarajan BT, Lewis CE, Kumar R, Han MK, Dransfield MT, Carnethon, Kalhan R.

Am J Med. 2019 Jul 29. pii: S0002-9343(19)30600-X. doi: 10.1016/j.amjmed.2019.06.049. [Epub ahead of print]

PMID:
31369720
3.

Overlap of Genetic Risk Between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Hobbs BD, Putman RK, Araki T, Nishino M, Gudmundsson G, Gudnason V, Eiriksdottir G, Zilhao Nogueira NR, Dupuis J, Xu H, O'Connor GT, Manichaikul A, Nguyen J, Podolanczuk AJ, Madahar P, Rotter JI, Lederer DJ, Barr RG, Rich SS, Ampleford EJ, Ortega VE, Peters SP, O'Neal WK, Newell JD Jr, Bleecker ER, Meyers DA, Allen RJ, Oldham JM, Ma SF, Noth I, Jenkins RG, Maher TM, Hubbard RB, Wain LV, Fingerlin TE, Schwartz DA, Washko GR, Rosas IO, Silverman EK, Hatabu H, Cho MH, Hunninghake GM; COPDGene Investigators, ECLIPSE Investigators, SPIROMICS Research Group, and UK ILD Consortium.

Am J Respir Crit Care Med. 2019 Jul 24. doi: 10.1164/rccm.201903-0511OC. [Epub ahead of print]

PMID:
31339356
4.

Heart and lungs in a single breath.

Washko GR, Agusti A.

Respirology. 2019 Oct;24(10):937-938. doi: 10.1111/resp.13641. Epub 2019 Jul 11. No abstract available.

5.

Radiographic pulmonary vessel volume, lung function and airways disease in the Framingham Heart Study.

Synn AJ, Li W, San José Estépar R, Zhang C, Washko GR, O'Connor GT, Araki T, Hatabu H, Bankier AA, Mittleman MA, Rice MB.

Eur Respir J. 2019 Sep 12;54(3). pii: 1900408. doi: 10.1183/13993003.00408-2019. Print 2019 Sep.

PMID:
31248956
6.

Objectively Measured Chronic Lung Injury on Chest CT.

Harmouche R, Ash SY, Putman RK, Hunninghake GM, San Jose Estepar R, Martinez FJ, Choi AM, Lynch DA, Hatabu H, Han MK, Bowler RP, Kalhan R, Rosas IO, Washko GR, San Jose Estepar R; COPDGene Investigators.

Chest. 2019 Jun 22. pii: S0012-3692(19)31197-3. doi: 10.1016/j.chest.2019.05.020. [Epub ahead of print]

PMID:
31233744
7.

Pulmonary vascular density: comparison of findings on computed tomography imaging with histology.

Rahaghi FN, Argemí G, Nardelli P, Domínguez-Fandos D, Arguis P, Peinado VI, Ross JC, Ash SY, de La Bruere I, Come CE, Diaz AA, Sánchez M, Washko GR, Barberà JA, San José Estépar R.

Eur Respir J. 2019 Aug 15;54(2). pii: 1900370. doi: 10.1183/13993003.00370-2019. Print 2019 Aug.

PMID:
31196942
8.

Harmonization of chest CT scans for different doses and reconstruction methods.

Vegas-Sánchez-Ferrero G, Ledesma-Carbayo MJ, Washko GR, San José Estépar R.

Med Phys. 2019 Jul;46(7):3117-3132. doi: 10.1002/mp.13578. Epub 2019 Jun 7.

PMID:
31069809
9.

Validation of Imaging Measures in Chronic Obstructive Pulmonary Disease.

Aaron CP, Washko GR.

Am J Respir Crit Care Med. 2019 Sep 1;200(5):524-525. doi: 10.1164/rccm.201902-0395ED. No abstract available.

PMID:
30836008
10.

Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Washko GR, Nardelli P, Ash SY, Vegas Sanchez-Ferrero G, Rahaghi FN, Come CE, Dransfield MT, Kalhan R, Han MK, Bhatt SP, Wells JM, Aaron CP, Diaz AA, Ross JC, Cuttica MJ, Labaki WW, Querejeta Roca G, Shah AM, Young K, Kinney GL, Hokanson JE, Agustí A, San José Estépar R.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):454-461. doi: 10.1164/rccm.201811-2063OC.

PMID:
30758975
11.

Cigarette Smoke Exposure and Radiographic Pulmonary Vascular Morphology in the Framingham Heart Study.

Synn AJ, Zhang C, Washko GR, Estépar RSJ, O'Connor GT, Li W, Mittleman MA, Rice MB.

Ann Am Thorac Soc. 2019 Jun;16(6):698-706. doi: 10.1513/AnnalsATS.201811-795OC.

PMID:
30714821
12.

Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.

Putman RK, Gudmundsson G, Axelsson GT, Hida T, Honda O, Araki T, Yanagawa M, Nishino M, Miller ER, Eiriksdottir G, Gudmundsson EF, Tomiyama N, Honda H, Rosas IO, Washko GR, Cho MH, Schwartz DA, Gudnason V, Hatabu H, Hunninghake GM.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):175-183. doi: 10.1164/rccm.201809-1652OC.

PMID:
30673508
13.

Quantification of the Pulmonary Vascular Response to Inhaled Nitric Oxide Using Noncontrast Computed Tomography Imaging.

Rahaghi FN, Winkler T, Kohli P, Nardelli P, Martí-Fuster B, Ross JC, Radhakrishnan R, Blackwater T, Ash SY, de La Bruere I, Diaz AA, Channick RN, Harris RS, Washko GR, San José Estépar R.

Circ Cardiovasc Imaging. 2019 Dec;12(1):e008338. doi: 10.1161/CIRCIMAGING.118.008338. No abstract available.

PMID:
30632391
14.

Association of outdoor temperature with lung function in a temperate climate.

Rice MB, Li W, Wilker EH, Gold DR, Schwartz J, Zanobetti A, Koutrakis P, Kloog I, Washko GR, O'Connor GT, Mittleman MA.

Eur Respir J. 2019 Jan 3;53(1). pii: 1800612. doi: 10.1183/13993003.00612-2018. Print 2019 Jan.

PMID:
30578386
15.

Rebuttal From Dr Washko.

Washko GR.

Chest. 2018 Dec;154(6):1281-1282. doi: 10.1016/j.chest.2018.08.1054. No abstract available.

PMID:
30526968
16.

POINT: Should Chest CT Be Part of Routine Clinical Care for COPD? Yes.

Washko GR.

Chest. 2018 Dec;154(6):1276-1278. doi: 10.1016/j.chest.2018.08.1053. No abstract available.

PMID:
30526966
17.

Airway fractal dimension predicts respiratory morbidity and mortality in COPD.

Bodduluri S, Puliyakote ASK, Gerard SE, Reinhardt JM, Hoffman EA, Newell JD Jr, Nath HP, Han MK, Washko GR, San José Estépar R, Dransfield MT, Bhatt SP; COPDGene Investigators.

J Clin Invest. 2018 Dec 3;128(12):5676. doi: 10.1172/JCI125987. Epub 2018 Dec 3. No abstract available.

18.

Pulmonary vascular pruning in smokers with bronchiectasis.

Diaz AA, Maselli DJ, Rahaghi F, Come CE, Yen A, Maclean ES, Okajima Y, Martinez CH, Yamashiro T, Lynch DA, Wang W, Kinney GL, Washko GR, San José Estépar R.

ERJ Open Res. 2018 Nov 23;4(4). pii: 00044-2018. doi: 10.1183/23120541.00044-2018. eCollection 2018 Oct.

19.

Inflammation and endothelial activation in early adulthood are associated with future emphysema: the CARDIA Lung Study.

Wells JM, Colangelo LA, Sivarajan L, Thyagarajan B, Dransfield MT, Iribarren C, Reyfman PA, Jacobs DR, Washko GR, Kalhan R.

Eur Respir J. 2019 Jan 17;53(1). pii: 1801532. doi: 10.1183/13993003.01532-2018. Print 2019 Jan. No abstract available.

PMID:
30464011
20.

Lung, Fat and Bone: Increased Adiponectin Associates with the Combination of Smoking-Related Lung Disease and Osteoporosis.

Suh YJ, McDonald MN, Washko GR, Carolan BJ, Bowler RP, Lynch DA, Kinney GL, Bon JM, Cho MH, Crapo JD, Regan EA; COPDGene Investigators.

Chronic Obstr Pulm Dis. 2018 Apr 1;5(2):134-143. doi: 10.15326/jcopdf.5.2.2016.0174.

21.

COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging.

Washko GR, Parraga G.

Eur Respir J. 2018 Nov 29;52(5). pii: 1801570. doi: 10.1183/13993003.01570-2018. Print 2018 Nov. Review.

PMID:
30337445
22.

Imaging Advances in Chronic Obstructive Pulmonary Disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study.

Bhatt SP, Washko GR, Hoffman EA, Newell JD Jr, Bodduluri S, Diaz AA, Galban CJ, Silverman EK, San José Estépar R, Lynch DA.

Am J Respir Crit Care Med. 2019 Feb 1;199(3):286-301. doi: 10.1164/rccm.201807-1351SO.

PMID:
30304637
23.

Airway fractal dimension predicts respiratory morbidity and mortality in COPD.

Bodduluri S, Puliyakote ASK, Gerard SE, Reinhardt JM, Hoffman EA, Newell JD Jr, Nath HP, Han MK, Washko GR, San José Estépar R, Dransfield MT, Bhatt SP; COPDGene Investigators.

J Clin Invest. 2018 Dec 3;128(12):5374-5382. doi: 10.1172/JCI120693. Epub 2018 Oct 29. Erratum in: J Clin Invest. 2018 Dec 3;128(12):5676.

24.

Life-Course Smoking Trajectories and Risk for Emphysema in Middle Age: The CARDIA Lung Study.

Mathew AR, Bhatt SP, Colangelo LA, Allen NB, Jacobs DR Jr, Auer R, Dransfield MT, Hitsman B, Washko GR, Kalhan R.

Am J Respir Crit Care Med. 2019 Jan 15;199(2):237-240. doi: 10.1164/rccm.201808-1568LE. No abstract available.

PMID:
30215529
25.

Deep learning for biomarker regression: application to osteoporosis and emphysema on chest CT scans.

González G, Washko GR, Estépar RSJ.

Proc SPIE Int Soc Opt Eng. 2018 Feb;10574. pii: 105741H. doi: 10.1117/12.2293455. Epub 2018 Mar 2.

26.

Automated Agatston Score Computation in non-ECG Gated CT Scans Using Deep Learning.

Cano-Espinosa C, González G, Washko GR, Cazorla M, Estépar RSJ.

Proc SPIE Int Soc Opt Eng. 2018 Feb;10574. pii: 105742K. doi: 10.1117/12.2293681. Epub 2018 Mar 2.

27.

Multiorgan structures detection using deep convolutional neural networks.

Onieva JO, Serrano GG, Young TP, Washko GR, Carbayo MJL, Estépar RSJ.

Proc SPIE Int Soc Opt Eng. 2018 Feb;10574. pii: 1057428. doi: 10.1117/12.2293761. Epub 2018 Mar 2.

28.

Pulmonary Artery-Vein Classification in CT Images Using Deep Learning.

Nardelli P, Jimenez-Carretero D, Bermejo-Pelaez D, Washko GR, Rahaghi FN, Ledesma-Carbayo MJ, San Jose Estepar R.

IEEE Trans Med Imaging. 2018 Nov;37(11):2428-2440. doi: 10.1109/TMI.2018.2833385. Epub 2018 May 4.

29.

Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort.

Ash SY, Harmouche R, Ross JC, Diaz AA, Rahaghi FN, Vegas Sanchez-Ferrero G, Putman RK, Hunninghake GM, Onieva Onieva J, Martinez FJ, Choi AM, Bowler RP, Lynch DA, Hatabu H, Bhatt SP, Dransfield MT, Wells JM, Rosas IO, San Jose Estepar R, Washko GR; COPDGene Investigators.

Radiology. 2018 Aug;288(2):600-609. doi: 10.1148/radiol.2018172688. Epub 2018 Jun 5.

30.

Identification of Chronic Obstructive Pulmonary Disease Axes That Predict All-Cause Mortality: The COPDGene Study.

Kinney GL, Santorico SA, Young KA, Cho MH, Castaldi PJ, San José Estépar R, Ross JC, Dy JG, Make BJ, Regan EA, Lynch DA, Everett DC, Lutz SM, Silverman EK, Washko GR, Crapo JD, Hokanson JE; COPDGene Investigators.

Am J Epidemiol. 2018 Oct 1;187(10):2109-2116. doi: 10.1093/aje/kwy087.

PMID:
29771274
31.

Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort.

Ash SY, Rahaghi FN, Come CE, Ross JC, Colon AG, Cardet-Guisasola JC, Dunican EM, Bleecker ER, Castro M, Fahy JV, Fain SB, Gaston BM, Hoffman EA, Jarjour NN, Mauger DT, Wenzel SE, Levy BD, San Jose Estepar R, Israel E, Washko GR; SARP Investigators.

Am J Respir Crit Care Med. 2018 Jul 1;198(1):39-50. doi: 10.1164/rccm.201712-2426OC.

32.

Longitudinal Modeling of Lung Function Trajectories in Smokers with and without Chronic Obstructive Pulmonary Disease.

Ross JC, Castaldi PJ, Cho MH, Hersh CP, Rahaghi FN, Sánchez-Ferrero GV, Parker MM, Litonjua AA, Sparrow D, Dy JG, Silverman EK, Washko GR, San José Estépar R.

Am J Respir Crit Care Med. 2018 Oct 15;198(8):1033-1042. doi: 10.1164/rccm.201707-1405OC.

PMID:
29671603
33.

Pectoralis muscle area and mortality in smokers without airflow obstruction.

Diaz AA, Martinez CH, Harmouche R, Young TP, McDonald ML, Ross JC, Han ML, Bowler R, Make B, Regan EA, Silverman EK, Crapo J, Boriek AM, Kinney GL, Hokanson JE, Estepar RSJ, Washko GR.

Respir Res. 2018 Apr 10;19(1):62. doi: 10.1186/s12931-018-0771-6.

34.

Defining Impaired Respiratory Health. A Paradigm Shift for Pulmonary Medicine.

Reyfman PA, Washko GR, Dransfield MT, Spira A, Han MK, Kalhan R.

Am J Respir Crit Care Med. 2018 Aug 15;198(4):440-446. doi: 10.1164/rccm.201801-0120PP. Review. No abstract available.

35.

Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers.

Ash SY, Harmouche R, Putman RK, Ross JC, Martinez FJ, Choi AM, Bowler RP, Regan EA, Curtis JL, Han MK, Boucher RC, O'Neal WK, Hatabu H, Lynch DA, Rosas IO, Hunninghake GM, San Jose Estepar R, Washko GR; COPDGene Investigators.

Thorax. 2018 Nov;73(11):1071-1074. doi: 10.1136/thoraxjnl-2017-211208. Epub 2018 Feb 13.

PMID:
29440587
36.

Susceptibility to Inhalational Lung Injury: We Need More Than the FEV1.

Washko GR.

Ann Am Thorac Soc. 2018 Feb;15(2):156-157. doi: 10.1513/AnnalsATS.201711-870ED. No abstract available.

PMID:
29388819
37.

Exposure to Traffic Emissions and Fine Particulate Matter and Computed Tomography Measures of the Lung and Airways.

Rice MB, Li W, Dorans KS, Wilker EH, Ljungman P, Gold DR, Schwartz J, Koutrakis P, Kloog I, Araki T, Hatabu H, San Jose Estepar R, O'Connor GT, Mittleman MA, Washko GR.

Epidemiology. 2018 May;29(3):333-341. doi: 10.1097/EDE.0000000000000809.

38.

Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study.

Kalhan R, Dransfield MT, Colangelo LA, Cuttica MJ, Jacobs DR Jr, Thyagarajan B, Estepar RSJ, Harmouche R, Onieva JO, Ash SY, Okajima Y, Iribarren C, Sidney S, Lewis CE, Mannino DM, Liu K, Smith LJ, Washko GR.

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1616-1624. doi: 10.1164/rccm.201710-2108OC.

PMID:
29369684
39.

Differences in Respiratory Symptoms and Lung Structure Between Hispanic and Non-Hispanic White Smokers: A Comparative Study.

Diaz AA, Rahaghi FN, Doyle TJ, Young TP, Maclean ES, Martinez CH, San José Estépar R, Guerra S, Tesfaigzi Y, Rosas IO, Washko GR, Wilson DO.

Chronic Obstr Pulm Dis. 2017 Sep 5;4(4):297-304. doi: 10.15326/jcopdf.4.4.2017.0150.

40.

Ensemble genomic analysis in human lung tissue identifies novel genes for chronic obstructive pulmonary disease.

Morrow JD, Cho MH, Platig J, Zhou X, DeMeo DL, Qiu W, Celli B, Marchetti N, Criner GJ, Bueno R, Washko GR, Glass K, Quackenbush J, Silverman EK, Hersh CP.

Hum Genomics. 2018 Jan 15;12(1):1. doi: 10.1186/s40246-018-0132-z.

41.

Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.

Bhatt SP, Kim YI, Harrington KF, Hokanson JE, Lutz SM, Cho MH, DeMeo DL, Wells JM, Make BJ, Rennard SI, Washko GR, Foreman MG, Tashkin DP, Wise RA, Dransfield MT, Bailey WC; COPDGene Investigators.

Thorax. 2018 May;73(5):414-421. doi: 10.1136/thoraxjnl-2017-210722. Epub 2018 Jan 11.

42.

Paratracheal Paraseptal Emphysema and Expiratory Central Airway Collapse in Smokers.

Copeland CR, Nath H, Terry NLJ, Wilson CG, Kim YI, Lynch DA, Bodduluri S, Wells JM, Dransfield MT, Díaz AA, Washko GR, Foreman MG, Bhatt SP; Genetic Epidemiology of COPD (COPDGene) Investigators.

Ann Am Thorac Soc. 2018 Apr;15(4):479-484. doi: 10.1513/AnnalsATS.201709-713OC.

43.

Autocalibration method for non-stationary CT bias correction.

Vegas-Sánchez-Ferrero G, Ledesma-Carbayo MJ, Washko GR, Estépar RSJ.

Med Image Anal. 2018 Feb;44:115-125. doi: 10.1016/j.media.2017.12.004. Epub 2017 Dec 8.

44.

Chest computed tomography-derived low fat-free mass index and mortality in COPD.

McDonald MN, Diaz AA, Rutten E, Lutz SM, Harmouche R, San Jose Estepar R, Kinney G, Hokanson JE, Gower BA, Wouters EFM, Rennard SI, Hersh CP, Casaburi R, Dransfield MT, Silverman EK, Washko GR.

Eur Respir J. 2017 Dec 14;50(6). pii: 1701134. doi: 10.1183/13993003.01134-2017. Print 2017 Dec.

45.

Handgrip Strength in Chronic Obstructive Pulmonary Disease. Associations with Acute Exacerbations and Body Composition.

Martinez CH, Diaz AA, Meldrum CA, McDonald MN, Murray S, Kinney GL, Hokanson JE, Curtis JL, Bowler RP, Han MK, Washko GR, Regan EA; COPDGene Investigators.

Ann Am Thorac Soc. 2017 Nov;14(11):1638-1645. doi: 10.1513/AnnalsATS.201610-821OC.

46.

Disease Severity Dependence of the Longitudinal Association Between CT Lung Density and Lung Function in Smokers.

Diaz AA, Strand M, Coxson HO, Ross JC, San Jose Estepar R, Lynch D, van Rikxoort EM, Rosas IO, Hunninghake GM, Putman RK, Hatabu H, Yen A, Kinney GL, Hokanson JE, Silverman EK, Crapo J, Washko GR.

Chest. 2018 Mar;153(3):638-645. doi: 10.1016/j.chest.2017.10.012. Epub 2017 Oct 21.

47.

CT imaging of chronic obstructive pulmonary disease: insights, disappointments, and promise.

Washko GR, Coxson HO, O'Donnell DE, Aaron SD.

Lancet Respir Med. 2017 Nov;5(11):903-908. doi: 10.1016/S2213-2600(17)30345-4. Epub 2017 Sep 28.

PMID:
28965820
48.

Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression.

Boueiz A, Chang Y, Cho MH, Washko GR, San José Estépar R, Bowler RP, Crapo JD, DeMeo DL, Dy JG, Silverman EK, Castaldi PJ; COPDGene Investigators.

Chest. 2018 Jan;153(1):65-76. doi: 10.1016/j.chest.2017.09.022. Epub 2017 Sep 21.

49.

Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections.

Miller ER, Putman RK, Vivero M, Hung Y, Araki T, Nishino M, Washko GR, Rosas IO, Hatabu H, Sholl LM, Hunninghake GM.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):955-958. doi: 10.1164/rccm.201708-1679LE. No abstract available.

50.

The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes.

Putman RK, Gudmundsson G, Araki T, Nishino M, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Ross JC, San José Estépar R, Miller ER, Yamada Y, Yanagawa M, Tomiyama N, Launer LJ, Harris TB, El-Chemaly S, Raby BA, Cho MH, Rosas IO, Washko GR, Schwartz DA, Silverman EK, Gudnason V, Hatabu H, Hunninghake GM.

Eur Respir J. 2017 Sep 11;50(3). pii: 1700537. doi: 10.1183/13993003.00537-2017. Print 2017 Sep.

Supplemental Content

Loading ...
Support Center